TB-500
TB-500 is supplied as a synthetic fragment of Thymosin Beta-4 for cell-motility and tissue-repair pathway research. Supplied strictly for laboratory and educational research. Not for human or veterinary use.
Vial amount
Purchase option
Checkout includes a research-use attestation. Materials are supplied only for laboratory and educational research.
TB-500 in research
TB-500 is supplied as a synthetic fragment of Thymosin Beta-4 for cell-motility and tissue-repair pathway research.
Growth-factor, matrix, and cell-model research with careful RUO positioning.
Bench context
Supplied as a research-grade reference material for documented laboratory and educational research workflows.
Available amounts
Select from the stocked vial amounts for TB-500 before adding the material to cart.
Claims discipline
No protocol instructions, no dosing, no medical advice, and no therapeutic or human-use promises.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, not for diagnostic or therapeutic use, not a drug or supplement.
As listed by the supplier in BioRegen's ordering system, shown here exactly as written for transparency. This is the vendor's own description, not independently verified, edited, or endorsed by BioRegen, and is not a BioRegen claim of any effect.
10mg
Disclaimer: All products on this site are for Research and Development use only. Products are Not for Human Consumption of any kind. The statements made within this website have not been evaluated by the U.S. Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Explore the fascinating world of Tb-500, a synthetic peptide that has captured the attention of researchers globally. Tb-500 is an analogue of Thymosin Beta-4, naturally found in the body, and is associated with the regulation of actin, a protein that plays a crucial role in cellular movement and structure. Its primary function is believed to be the enhancement of cellular building blocks, which may aid in quicker recovery and tissue repair.
Research into Tb-500 focuses on its potential to support the body's natural healing processes. Scientists are particularly interested in its ability to promote cell migration and proliferation, which are essential for effective tissue regeneration. This makes Tb-500 a subject of interest in studies related to wound healing and recovery from injuries.
While Tb-500's potential is promising, it is important to note that all research is ongoing, and findings are continually developing. With its unique properties, Tb-500 remains a key area of interest in the field of regenerative medicine and peptide research.
The full research picture, clearly labeled
BioRegen reports the entire research landscape for this compound across four clearly separated tiers, strongest evidence first. Lower tiers, including community and anecdotal reports, are labeled as such and are not BioRegen claims.
Controlled human clinical trial data for BPC-157 is very limited. The large majority of published research is preclinical, and widely repeated claims of human benefit are not supported by robust controlled human trials.
Extensive rodent and in-vitro research has examined BPC-157 in tissue-repair, tendon and ligament healing, angiogenesis, and gut-protection models, reporting consistent healing-associated effects in those animal models.
BPC-157 is one of the most-discussed peptides in recovery, fitness, and biohacker communities, where individuals share anecdotal recovery reports. These are unverified anecdotal reports, not controlled findings, and not BioRegen claims.
Not approved by the FDA for human use; in its review of bulk compounding substances the FDA identified BPC-157 as raising safety and characterization concerns. BioRegen supplies BPC-157 reference material strictly for laboratory and educational research, not for human use.
Tiers are evidence categories, not endorsements. Clinical and preclinical entries summarize third-party published research. Community and anecdotal entries are unverified reports discussed by others, not findings and not BioRegen claims. Nothing here is medical advice, and no compound is approved for human or veterinary use except where explicitly stated under Regulatory status.
What the published research says about TB-500
This section reports on published research referenced in BioRegen's own research library. It is not a claim by BioRegen that the compound provides any benefit, and nothing here is medical advice.
- [1] Gwyer D, Wragg NM, Wilson SL (2019). Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. doi:10.1007/s00441-019-03016-8
- [2] Seiwerth S, et al. (2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Front Pharmacol. doi:10.3389/fphar.2021.627533